Stifel raises Ambiq Micro stock price target to $85 on edge AI potential

Stifel has increased its price target for Ambiq Micro Inc (NYSE:AMBQ) stock to $85.00, up from the previous $75.00 rating. The firm maintains a Buy rating for Ambiq, citing the company's SPOT platform semiconductor technology as a key competitive advantage. This technology allows for higher compute performance at lower power levels compared to existing transistor technologies.

Ambiq's stock has shown strong performance, up 129% over the past year and 139% year-to-date. However, InvestingPro analysis indicates the shares may be overvalued at current levels. Ambiq is well-positioned to benefit from the edge AI semiconductor solutions market, as the company transitions toward higher-margin non-China applications, with China accounting for only 14% of its second-quarter 2026 revenue.

The firm expects a significant inflection point in the first half of 2026, fueled by the expansion of Ambiq's customer base across a wider range of applications. The launch of Ambiq's next-generation AI-focused Atomiq product platform could further accelerate growth at higher margins. Stifel projects double-digit revenue growth in 2026, with non-GAAP gross margins improving to 45.0% in 2025 from 31.5% in 2024.

Although the company remains unprofitable with a net loss of $2.02 per share, revenue grew by 32% in the last twelve months to $97.87 million. Ambiq's second-quarter performance saw an impressive 89.7% revenue increase to $33.9 million, and the company raised its full-year sales outlook to approximately $135 million. Recent analyst actions include UBS raising its price target to $73 and BofA Securities increasing its target to $75, both citing strong demand growth in wearables and new applications in medical, industrial, and smart-home sectors.

Despite these positive developments, both UBS and BofA Securities maintain their Neutral and Underperform ratings on Ambiq Micro stock.